Skip to main navigation Skip to search Skip to main content

End to End Continuous Manufacturing: Integration of Unit Operations

  • R. Lakerveld
  • , P. L. Heider
  • , K. D. Jensen
  • , R. D. Braatz
  • , K. F. Jensen
  • , A. S. Myerson
  • , B. L. Trout

Research output: Chapter in Book/Conference Proceeding/ReportBook Chapterpeer-review

Abstract

This chapter discusses the challenges and opportunities when fully integrating a continuous manufacturing (CM) process for pharmaceuticals from end to end. It provides a brief overview of the key unit operations in the process for completeness. The chapter also presents a realistic case study to support the discussion with real-life examples from pilot plant experiments. The chapter discusses the role of system dynamics and the role of process analytical technology (PAT) in the studied pilot plant. In addition, the chapter also briefly discusses the relation between PAT and process models to estimate unknown process variables for monitoring and automated control. Moreover, novel technologies that are currently under development are expected to further enhance CM of pharmaceuticals. The chapter further discusses examples of such future technologies. It ends with a chapter summary and discussion of benefits and challenges of CM of pharmaceuticals.
Original languageEnglish
Title of host publicationContinuous Manufacturing of Pharmaceuticals
PublisherJohn Wiley & Sons Ltd
Pages447-483
Number of pages37
ISBN (Electronic)9781119001348
ISBN (Print)9781119001324
DOIs
Publication statusPublished - 14 Jul 2017

Bibliographical note

Publisher Copyright:
© 2017 John Wiley & Sons Ltd. All rights reserved.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 9 - Industry, Innovation, and Infrastructure
    SDG 9 Industry, Innovation, and Infrastructure

Fingerprint

Dive into the research topics of 'End to End Continuous Manufacturing: Integration of Unit Operations'. Together they form a unique fingerprint.

Cite this